We are live on ! Find out more
PSTV

Plus Therapeutics
PSTV

Delisted

PSTV was delisted on the 31st of July, 2026.

Back to rankings

5 hedge funds and large institutions have $7.87M invested in Plus Therapeutics in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more funds holding

Funds holding: 4 → 5 (+1)

56% less capital invested

Capital invested by funds: $18M → $7.87M (-$10.1M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $11K

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
3
Reduced
–
Closed
–
Calls
–
Puts
$11K
Net Calls
-$11K
Net Calls Change
-$11K

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$4.18M
2
AFM
Anson Funds Management
Texas
+$1.79M
3
PCM
Perkins Capital Management
Minnesota
+$597K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$597K

Top Sellers

Rank Fund Capital Flow
1
CA
Cambridge Associates
Massachusetts
-$852K
2
RAM
Redmond Asset Management
Virginia
-$135K
3
Goldman Sachs
Goldman Sachs
New York
-$28K
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$23K
5
VKH
Virtu KCG Holdings
New York
-$22K
Name Holding Trade Value Shares
Change 		Change in
Stake
TDC
26
Thompson Davis & Co
Virginia
$2K – – –
TRCT
27
Tower Research Capital (TRC)
New York
$2K – – –
Bank of America
28
Bank of America
North Carolina
$1K – – –
Manulife (Manufacturers Life Insurance)
29
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K – – –
Wells Fargo
30
Wells Fargo
California
$1K – – –
WP
31
WealthPLAN Partners
Nebraska
$378 – – –
ACM
32
Argentus Capital Management
Texas
– -$2K – –
Bank of New York Mellon
33
Bank of New York Mellon
New York
– -$23K – –
CA
34
Cambridge Associates
Massachusetts
– -$852K – –
Citadel Advisors
35
Citadel Advisors
Florida
– -$10K – –
CB
36
Commerce Bank
Missouri
– -$20K – –
Commonwealth Equity Services
37
Commonwealth Equity Services
Massachusetts
– -$7K – –
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
– -$5K – –
FCI
39
Financial Counselors Inc
Kansas
– -$9K – –
FIM
40
Freedom Investment Management
Connecticut
– -$6K – –
Goldman Sachs
41
Goldman Sachs
New York
– -$28K – –
Group One Trading
42
Group One Trading
Illinois
– -$6K – –
GC
43
Guggenheim Capital
Illinois
– -$12K – –
HSA
44
HBK Sorce Advisory
Pennsylvania
– -$5K – –
Janney Montgomery Scott
45
Janney Montgomery Scott
Pennsylvania
– -$4K – –
LPL Financial
46
LPL Financial
California
– -$10K – –
MCM
47
Marathon Capital Management
Maryland
– -$14K – –
Mariner
48
Mariner
Kansas
– -$3K – –
NFG
49
Noven Financial Group
Colorado
– -$11K – –
OC
50
Oppenheimer & Co
New York
– -$18K – –
1
2
3

PSTV Hedge Fund Activity: Q2 2016 in Review

5 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q2 2016, worth a combined $7.87M — down 56% from $18M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new PSTV positions and 0 closed out — a net gain of 1 holder — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, adding an estimated $4.18M. The largest seller was Cambridge Associates, cutting an estimated $852K.

  • 5 institutional investors held Plus Therapeutics (PSTV) as of Q2 2016, up from 4 in Q1 2016.
  • Funds reported $7.87M of Plus Therapeutics stock for Q2 2016, down 56% quarter-over-quarter.
  • 1 fund opened new Plus Therapeutics positions in Q2 2016 and 0 closed out, a net change of +1 holder.
  • The largest Plus Therapeutics buyer in Q2 2016 was Sabby Management, an estimated $4.18M added.
  • The largest Plus Therapeutics seller in Q2 2016 was Cambridge Associates, an estimated $852K sold.

Based on aggregated 13F filings for Q2 2016.